Lowenstein-Jensen medium after 42 days. On MPT64 immunochromatographic card test, growth was identifi ed as M. tuberculosis complex. Detailed examination ruled out any primary focus in the body. Directly observed treatment short course (DOTS) was started [2] and patient has shown improvement with complete regression of the thoracic mass.
Atypical presentation, paucibacillary nature and negative AFB smear makes the diagnosis diffi cult and time consuming, thereby, delaying the initiation of treatment leading to complications and mortality in a treatable disease. [3] This case emphasises that tuberculosis should be kept in mind as differential diagnosis when a case present with isolated thoracic wall abscess, in immunocompetent persons in endemic areas. 
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Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant Staphylococcus Aureus (MRSA)
Dear Editor, Antimicrobial resistance is a major concern in a clinical set-up. Newer pathogens are emerging day by day which pose a major threat in treating hospitalised patients. This correspondence highlights the bacteria which so far considered as a commensal has reached the status of highly virulent pathogen. The vancomycin-resistant enterococcus (VRE) is attaining virulence as Methicillin-resistant Staphylococcus aureus (MRSA). The incidence is more compared to MRSA. The key message is to highlight the importance of VRE strains that is increasingly seen in wound infections. Enterococcus was normally ignored by many clinicians in clinical samples as it is normal fl ora. But now it stands individually in most of the recurrent infections and interferes with the healing of wound. The source is always noted to be the faecal fl ora.
The recent studies show that VRE is emerging as a major threat in postoperative sepsis, which delays the process of wound healing. It is of utmost concern because it is a part of the normal fl ora in our body and in most sepsis, its occurrence is from an endogenous source only. This is evident in cases which show recurrence of sepsis with the bacterial strains with almost same sensitivity patterns. A comparison of the incidence rates of VRE and MRSA were analysed based on four categories from previous studies and the results were attained. Based on percentage of resistant strains isolated in the study by National Nosocomial Infections From the analysis of various reports, we see that in most of the cases reported earlier, the MRSA incident were higher and was considered seriously whereas the VRE incidences were neglected. But in the recent reports and reviews, we fi nd out that the VRE incidents have risen up at alarming rates and are almost equal to the MRSA incidence rates. If this rate is continued we will fi nally have no antibiotics at all to protect us at all. Preventive measures like washing the hands, dressing of wound, etc., if followed properly the incidence of MRSA and VRE rates can defi nitely be reduced. So the probable sustainable solution is to stop uncontrolled and unwarranted use of antibiotics and use antibiotics with justifi cation!! Surveillance (NNIS) System, USA, VRE-resistant Enterococi among intensive care unit (ICU) patients, 1995-2004, the percent of S. aureus infections caused by methicillin-resistant strains increased from approximately 40-60% and similarly when we compare the VRE percentage rates, it also showed an increase from approximately 24.9-28.5% which is quiet signifi cant when compared individually. [1] Based on number of bacteremias in a study by Ontario Medical Association, MRSA and VRE Bacteremias in Ontario, 1992-2004, Canada, the MRSA and VRE incidence rates based on number of bacteremias between the years 2003-2004 were analysed. It revealed a slight increase in the number of MRSA bacteremias, whereas the VRE bacteremia incidents increased many folds compared to MRSA. [2] Similarly based on rate of infection incidences in a study by Dr. Elizabeth Bryce et al., Vancover Coastal Health Infection Control Annual Report 2010-2011, the 2009 National Canadian Nosocomial Infection Surveillance Program (CNISP) rate for MRSA is 5.89 per 10,000 inpatient days, whereas the 2009 national CNISP rate for VRE is 5.44 per 10,000 inpatient days [3] and fi nally according to the Blood Stream Infection (BSI) incidence rates by hospital category in the study by California Department of Public Health Technical Report, from overall among 361 reporting hospitals, reporting at least 10 months of data, there were 908 MRSA and 788 VRE BSIs during 16,207,201 patient days. The pooled mean incidence rate of MRSA BSIs and VRE BSIs per 10,000 patient days was 0.6 and 0.5, respectively. [4] The cumulative data from the various studies analysed are tabulated in Table 1 . 
VRE incidents
Based on percentage of resistant strains isolated [1] ; From (1990s-2003 40-60% (↑) 24.9-28.5% (↑)
Based on number of bacteremias [2] ; between (2003) (2004) 210-260 bacteremias (↑)
3-15 bacteremias (↑)
Based on rate of infection incidences [3] ; CNISP rate per 10,000 inpatient days (1995-2009) 5.89 5.44 BSI incidence rates by hospital category [4] ; 
